These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Gentle, fast and effective crystal soaking by acoustic dispensing. Collins PM; Ng JT; Talon R; Nekrosiute K; Krojer T; Douangamath A; Brandao-Neto J; Wright N; Pearce NM; von Delft F Acta Crystallogr D Struct Biol; 2017 Mar; 73(Pt 3):246-255. PubMed ID: 28291760 [TBL] [Abstract][Full Text] [Related]
24. High-throughput protein crystallography and drug discovery. Tickle I; Sharff A; Vinkovic M; Yon J; Jhoti H Chem Soc Rev; 2004 Oct; 33(8):558-65. PubMed ID: 15480479 [TBL] [Abstract][Full Text] [Related]
25. Electron density guided fragment-based drug design--a lead generation example. Abad MC; Gibbs AC; Zhang X Methods Enzymol; 2011; 493():487-508. PubMed ID: 21371603 [TBL] [Abstract][Full Text] [Related]
26. SPR-based fragment screening: advantages and applications. Neumann T; Junker HD; Schmidt K; Sekul R Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772 [TBL] [Abstract][Full Text] [Related]
31. Lead generation and examples opinion regarding how to follow up hits. Orita M; Ohno K; Warizaya M; Amano Y; Niimi T Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599 [TBL] [Abstract][Full Text] [Related]
32. Protein crystallography and fragment-based drug design. Caliandro R; Belviso DB; Aresta BM; de Candia M; Altomare CD Future Med Chem; 2013 Jun; 5(10):1121-40. PubMed ID: 23795969 [TBL] [Abstract][Full Text] [Related]
33. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening. Yokoyama T; Kitakami R; Mizuguchi M Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603 [TBL] [Abstract][Full Text] [Related]
34. Automated crystal mounting and data collection for protein crystallography. Muchmore SW; Olson J; Jones R; Pan J; Blum M; Greer J; Merrick SM; Magdalinos P; Nienaber VL Structure; 2000 Dec; 8(12):R243-6. PubMed ID: 11188700 [TBL] [Abstract][Full Text] [Related]
35. Efficiency of hit generation and structural characterization in fragment-based ligand discovery. Larsson A; Jansson A; Åberg A; Nordlund P Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447 [TBL] [Abstract][Full Text] [Related]
36. Hitting the target: fragment screening with acoustic in situ co-crystallization of proteins plus fragment libraries on pin-mounted data-collection micromeshes. Yin X; Scalia A; Leroy L; Cuttitta CM; Polizzo GM; Ericson DL; Roessler CG; Campos O; Ma MY; Agarwal R; Jackimowicz R; Allaire M; Orville AM; Sweet RM; Soares AS Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1177-89. PubMed ID: 24816088 [TBL] [Abstract][Full Text] [Related]
37. Mass spectrometry for fragment screening. Chan DS; Whitehouse AJ; Coyne AG; Abell C Essays Biochem; 2017 Nov; 61(5):465-473. PubMed ID: 28986384 [TBL] [Abstract][Full Text] [Related]
38. Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis. Ginn HM Acta Crystallogr D Struct Biol; 2020 Nov; 76(Pt 11):1134-1144. PubMed ID: 33135684 [TBL] [Abstract][Full Text] [Related]
39. Counting on Fragment Based Drug Design Approach for Drug Discovery. Kashyap A; Singh PK; Silakari O Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406 [TBL] [Abstract][Full Text] [Related]
40. Fragment-based drug discovery and its application to challenging drug targets. Price AJ; Howard S; Cons BD Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]